Cargando…
Third booster vaccination and stopping the Omicron, a new variant of concern
The SARS-CoV-2 omicron variant is recent member of variant of concerns that confer neutralizing antibodies and escape immune system due to harboring more than 40 mutations. Current evidences suggest two dosages SARS-CoV-2 vaccine dose not efficient protects against new variants of SARS-CoV-2; howeve...
Autores principales: | Ghazvini, Kiarash, Karbalaei, Mohsen, Keikha, Masoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259195/ https://www.ncbi.nlm.nih.gov/pubmed/35818430 http://dx.doi.org/10.1016/j.vacun.2022.05.005 |
Ejemplares similares
-
Third booster vaccination and stopping the Omicron, a new variant of concern
por: Ghazvini, Kiarash, et al.
Publicado: (2022) -
Clinical efficacy of vitamin D supplementation on pulmonary TB patients: The evidence of clinical trials
por: Karbalaei, Mohsen, et al.
Publicado: (2020) -
What are the clinical benefits of tocilizumab for COVID-19 patients? Evidence from available case-control studies
por: Ghazvini, Kiarash, et al.
Publicado: (2021) -
Multivalent vaccines against new SARS-CoV-2 hybrid variants
por: Ghazvini, Kiarash, et al.
Publicado: (2023) -
Multivalent vaccines against new SARS-CoV-2 hybrid variants
por: Ghazvini, Kiarash, et al.
Publicado: (2023)